This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Li, Y. Articles by Fuchs, S. Y. Search for Related Content PubMed PubMed Citation Articles by Li, Y. Articles by Fuchs, S. Y.

Negative Regulation of Prolactin Receptor Stability and Signaling Mediated by SCF^ß-TrCP E3 Ubiquitin Ligase

Department of Animal Biology, University of Pennsylvania, Philadelphia, Pennsylvania 19104,¹ AMC Cancer Center, Lakewood, Colorado 80214²

Received 24 November 2003/ Returned for modification 22 December 2003/ Accepted 10 February 2004

Ubiquitin-dependent degradation of hormone receptors is emerging as a key mechanism that regulates the magnitude and duration of hormonal effects on cells and tissues. The pituitary hormone prolactin (PRL) is involved in regulating cell differentiation, proliferation, and survival. PRL engages its receptor (PRLR) to initiate various signaling cascades, including the phosphorylation and activation of Stat5. We found that PRL promotes interaction between PRLR and the F-box protein ß-TrCP2, which functions as a substrate recognition subunit of the SCF^ß-TrCP E3 ubiquitin ligase. This interaction requires PRLR phosphorylation and the integrity of serine 349 within a conserved motif, which is similar to conserved motifs present in other substrates of SCF^ß-TrCP. The PRLR^S349A mutant is resistant to ubiquitination and is more stable than its wild-type counterpart. Phosphorylated PRLR undergoes ubiquitination by SCF^ß-TrCP in vitro. Knockdown of ß-TrCP expression inhibits the ubiquitination and degradation of PRLR and promotes PRL-dependent phosphorylation of Stat5 as well as Stat5-dependent transcription in cells. Furthermore, the activation of Stat5 and the stimulation of cell growth by PRL are augmented in cells expressing the PRLR^S349A mutant. These data indicate that PRLR is a novel SCF^ß-TrCP substrate and implicate ß-TrCP as an important negative regulator of PRL signaling and cellular responses to this hormone.

This article has been cited by other articles:

• Kumar, K. G. S., Varghese, B., Banerjee, A., Baker, D. P., Constantinescu, S. N., Pellegrini, S., Fuchs, S. Y. (2008). Basal Ubiquitin-independent Internalization of Interferon {alpha} Receptor Is Prevented by Tyk2-mediated Masking of a Linear Endocytic Motif. J. Biol. Chem. 283: 18566-18572 [Abstract] [Full Text]  
• Plotnikov, A., Li, Y., Tran, T. H., Tang, W., Palazzo, J. P., Rui, H., Fuchs, S. Y. (2008). Oncogene-Mediated Inhibition of Glycogen Synthase Kinase 3{beta} Impairs Degradation of Prolactin Receptor. Cancer Res. 68: 1354-1361 [Abstract] [Full Text]  
• Swaminathan, G., Varghese, B., Thangavel, C., Carbone, C. J, Plotnikov, A., Kumar, K G S., Jablonski, E. M, Clevenger, C. V, Goffin, V., Deng, L., Frank, S. J, Fuchs, S. Y (2008). Prolactin stimulates ubiquitination, initial internalization, and degradation of its receptor via catalytic activation of Janus kinase 2. J Endocrinol 196: R1-R7 [Abstract] [Full Text]  
• Kumar, K.G. S., Barriere, H., Carbone, C. J., Liu, J., Swaminathan, G., Xu, P., Li, Y., Baker, D. P., Peng, J., Lukacs, G. L., Fuchs, S. Y. (2007). Site-specific ubiquitination exposes a linear motif to promote interferon-{alpha} receptor endocytosis. J. Cell Biol. 179: 935-950 [Abstract] [Full Text]  
• van Kerkhof, P., Putters, J., Strous, G. J. (2007). The Ubiquitin Ligase SCF(betaTrCP) Regulates the Degradation of the Growth Hormone Receptor. J. Biol. Chem. 282: 20475-20483 [Abstract] [Full Text]  
• Deng, L., He, K., Wang, X., Yang, N., Thangavel, C., Jiang, J., Fuchs, S. Y., Frank, S. J. (2007). Determinants of Growth Hormone Receptor Down-Regulation. Mol. Endocrinol. 21: 1537-1551 [Abstract] [Full Text]  
• Meyer, L., Deau, B., Forejtnikova, H., Dumenil, D., Margottin-Goguet, F., Lacombe, C., Mayeux, P., Verdier, F. (2007). {beta}-Trcp mediates ubiquitination and degradation of the erythropoietin receptor and controls cell proliferation. Blood 109: 5215-5222 [Abstract] [Full Text]  
• Jiang, Q., Huang, J., Li, W. Q., Cavinato, T., Keller, J. R., Durum, S. K. (2007). Role of the Intracellular Domain of IL-7 Receptor in T Cell Development. J. Immunol. 178: 228-234 [Abstract] [Full Text]  
• Staub, O., Rotin, D. (2006). Role of Ubiquitylation in Cellular Membrane Transport. Physiol. Rev. 86: 669-707 [Abstract] [Full Text]  
• Lu, J.-C., Piazza, T. M., Schuler, L. A. (2005). Proteasomes Mediate Prolactin-induced Receptor Down-regulation and Fragment Generation in Breast Cancer Cells. J. Biol. Chem. 280: 33909-33916 [Abstract] [Full Text]  
• Wan, M., Huang, J., Jhala, N. C., Tytler, E. M., Yang, L., Vickers, S. M., Tang, Y., Lu, C., Wang, N., Cao, X. (2005). SCF{beta}-TrCP1 Controls Smad4 Protein Stability in Pancreatic Cancer Cells. Am. J. Pathol. 166: 1379-1392 [Abstract] [Full Text]  
• Tang, W., Li, Y., Yu, D., Thomas-Tikhonenko, A., Spiegelman, V. S., Fuchs, S. Y. (2005). Targeting {beta}-Transducin Repeat-Containing Protein E3 Ubiquitin Ligase Augments the Effects of Antitumor Drugs on Breast Cancer Cells. Cancer Res. 65: 1904-1908 [Abstract] [Full Text]  
• Kumar, K. G. S., Krolewski, J. J., Fuchs, S. Y. (2004). Phosphorylation and Specific Ubiquitin Acceptor Sites Are Required for Ubiquitination and Degradation of the IFNAR1 Subunit of Type I Interferon Receptor. J. Biol. Chem. 279: 46614-46620 [Abstract] [Full Text]  
• Kudo, Y., Guardavaccaro, D., Santamaria, P. G., Koyama-Nasu, R., Latres, E., Bronson, R., Yamasaki, L., Pagano, M. (2004). Role of F-Box Protein {beta}Trcp1 in Mammary Gland Development and Tumorigenesis. Mol. Cell. Biol. 24: 8184-8194 [Abstract] [Full Text]